Abstract: |
Vaccinia DNA topoisomerase, a member of the eukaryotic type I enzyme family, binds duplex DNA and forms a covalent protein. DNA complex at sites containing a conserved sequence element 5'-CCCTT ↓ . The structure of the enzyme in the free and DNA-bound states was probed by limited proteolysis. The free topoisomerase (a 314-amino acid polypeptide) consists of protease- resistant amino- and carboxyl-terminal structural domains flanking a protease-sensitive 'hinge.' The hinge region, located between residues 135 and 142, is defined by accessibility to three different proteases. The amino- terminal region is punctuated by a trypsin-sensitive 'bridge' at Arg-80, suggesting at least a tripartite domain structure overall. A specific subset of residues accessible to proteases in the free enzyme becomes resistant to proteolysis in the DNA-bound state. The trypsin-sensitive site at Arg-80 is protected almost completely in the covalent complex. Within the hinge region, Lys-135, Tyr-136, and Glu-139 are protected from trypsin, chymotrypsin, and V8, respectively. Acquisition of altered protease sensitivity upon DNA binding occurs prior to covalent adduct formation. The 20-kDa carboxyl domain by itself binds noncovalently to duplex DNA, albeit without the sequence specificity characteristic of the full-sized topoisomerase. |
Keywords: |
sequence analysis; nonhuman; comparative study; polymerase chain reaction; protein conformation; animal; carboxy terminal sequence; protein degradation; cloning, molecular; dna; double stranded dna; amino acid sequence; conserved sequence; molecular sequence data; amino terminal sequence; kinetics; peptide fragments; recombinant proteins; vaccinia virus; base sequence; dna flanking region; binding sites; conformational transition; sequence homology, nucleic acid; dna binding; enzyme structure; chymotrypsin; autoradiography; dna topoisomerase; dna topoisomerases, type i; oligodeoxyribonucleotides; vaccinia; dna protein complex; restriction mapping; human; priority journal; article; support, non-u.s. gov't; support, u.s. gov't, p.h.s.
|